July 03, 2018 Shikeda masks slow second quarter for buyouts The money spent on biopharma acquisitions in the second quarter looks huge, but most of the total is down to one deal.
May 29, 2018 Canada’s medical cannabis ambition no laughing matter Growing acceptance of medical marijuana could see cannabis companies coming after pharma sales.
